Table IV.
Predictive factors for the final mHHS
| Variables | B | β | t | P | F | Adapted R2 |
|---|---|---|---|---|---|---|
| Female | 2.088 | 0.073 | 0.614 | 0.541 | 3.045 | 0.412 |
| Age | −0.223 | −0.093 | −0.725 | 0.471 | ||
| Height | −0.272 | −0.249 | −0.500 | 0.618 | ||
| Weight | 0.403 | 0.343 | 0.373 | 0.710 | ||
| BMI | −1.031 | −0.276 | −0.412 | 0.681 | ||
| Left side | −1.119 | −0.049 | −0.486 | 0.628 | ||
| Comorbidity | −4.745 | −0.118 | −1.090 | 0.279 | ||
| Treatment history | −1.595 | −0.064 | −0.627 | 0.533 | ||
| Hartofilakidis Type III | −0.239 | −0.010 | −0.096 | 0.924 | ||
| Pre-operative femoral anteversion | −0.191 | −0.220 | −1.654 | 0.102 | ||
| Combined with femoral osteotomy | 7.340 | 0.210 | 1.601 | 0.114 | ||
| Post-operative femoral anteversion | 0.064 | 0.032 | 0.294 | 0.769 | ||
| Capsular quality | 1.347 | 0.059 | 0.537 | 0.593 | ||
| Capsular thickness | 4.246 | 0.379 | 3.260 | 0.002 | ||
| Mean femoral head diameter | −0.430 | −0.198 | −1.481 | 0.143 | ||
| New socket diameter | 0.387 | 0.195 | 1.447 | 0.152 | ||
| Follow-up time | 0.125 | 0.242 | 2.469 | 0.016 |
The bold-faced entries indicate statistically significant results.